Please login to the form below

Not currently logged in

Spectrum Pharmaceuticals supports Fusilev with digital marketing campaign

Campaign for cancer drug includes a new website, HCP education tools and resources, and live programmes

US-based Spectrum Pharmaceuticals has launched a digital marketing campaign for its colorectal cancer drug Fusilev (levoleucovorin).

Featuring a new website, healthcare professional (HCP)educational tools, and live peer-to-peer educational programmes, the campaign will be aimed at oncologists, nurses, office practice managers and pharmacists.

"Strong commercial support for Fusilev has been rewarded by increased market penetration and sustained customer loyalty," said Rajesh Shrotriya, chairman, chief executive officer, and president of Spectrum Pharmaceuticals.

“We believe this campaign will continue to raise awareness of the Fusilev brand as well as grow the folate analog market."

20th August 2012


Featured jobs

Subscribe to our email news alerts


Add my company
Blue Latitude Health

Blue Latitude Health is a creative marketing consultancy. Founded in 2003, our combination of heritage, approach and capability gives us...

Latest intelligence

Retaining reader value in plain language summaries of clinical studies
Balancing the risk of misinterpretation with the public’s ability to understand simplified plain-language summaries...
Can we talk about the ego-bias and chemicals influencing your target audience’s behaviour?
Over the Summer, the Page & Page team became fascinated by two books on this very subject. Two books from one author, Dean Burnett, an eminent neuroscientist, lecturing at Cardiff...
Making Europe a leader in bioscience: boosting trust and opening minds
A vision of Paris as Europe's leading hub for life sciences innovation...